Abstract
Background
Exacerbated oxidative stress is thought to be a mediator of arterial hypertension. It has been postulated that creatine (Cr) could act as an antioxidant agent preventing increased oxidative stress. The aim of this study was to investigate the effects of nine weeks of Cr or placebo supplementation on oxidative stress and cardiovascular parameters in spontaneously hypertensive rats (SHR).
Findings
Lipid hydroperoxidation, one important oxidative stress marker, remained unchanged in the coronary artery (Cr: 12.6 ± 1.5 vs. Pl: 12.2 ± 1.7 nmol·mg-1; p = 0.87), heart (Cr: 11.5 ± 1.8 vs. Pl: 14.6 ± 1.1 nmol·mg-1; p = 0.15), plasma (Cr: 67.7 ± 9.1 vs. Pl: 56.0 ± 3.2 nmol·mg-1; p = 0.19), plantaris (Cr: 10.0 ± 0.8 vs. Pl: 9.0 ± 0.8 nmol·mg-1; p = 0.40), and EDL muscle (Cr: 14.9 ± 1.4 vs. Pl: 17.2 ± 1.5 nmol·mg-1; p = 0.30). Additionally, Cr supplementation affected neither arterial blood pressure nor heart structure in SHR (p > 0.05).
Conclusions
Using a well-known experimental model of systemic arterial hypertension, this study did not confirm the possible therapeutic effects of Cr supplementation on oxidative stress and cardiovascular dysfunction associated with arterial hypertension.
Electronic supplementary material
The online version of this article (doi:10.1186/1550-2783-9-13) contains supplementary material, which is available to authorized users.
Copyright comment
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Introduction
It has been suggested that exacerbated oxidative stress and its consequent oxidative damage may be mediators involved in cardiovascular diseases, such as systemic arterial hypertension [Citation1]. Supporting this notion, a reduction in antioxidant bioavailability along with increased oxidative stress has been reported in both experimental and human hypertension [Citation2].
Creatine (Cr) supplementation has emerged as a promising adjunct therapy in several pathological conditions [Citation3], including cardiovascular diseases [Citation4, Citation5]. Interestingly, a growing body of experimental and clinical literature has suggested that Cr may exert protective effect in diseases where exacerbated oxidative stress plays a detrimental role (e.g., Huntington's disease) [Citation6–Citation8]. In fact, in vitro experiments have revealed that Cr may possess antioxidant properties by acting as a scavenger of free radicals, such as superoxide anions and peroxynitrite [Citation8, Citation9]. For instance, Cr pre-loading was found to be cytoprotective in different cell cultures with oxidative stressors (i.e., H2O2, tBOOH and peroxynitrite) [Citation10]. Moreover, Cr may also "indirectly" attenuate the formation of reactive oxygen species trough the coupling of Cr with ATP into the mitochondria, ultimately resulting in a more efficient mitochondrial respiration and delayed accumulation of ADPf (i.e., the concentration of unbound ADP in the cytoplasm), which has been implicated in IMP and subsequently ROS formation [Citation8, Citation11]. This latter, in turn, may lead to oxidative stress with formation of chemical products of ROS reactions, such as oxidised glutathione and lipid hydroperoxides [Citation12]. Despite the potential antioxidant capacity of Cr supplementation, its effects on oxidative stress and, consequently, cardiovascular parameters in experimental models of hypertension are still unknown.
This is a short-report on the effects of Cr supplementation on oxidative stress, heart structure, and arterial blood pressure in spontaneously hypertensive rats (SHR), a well-established experimental model of arterial hypertension [Citation13].
Material and methods
Procedures
This study was approved by the institution's ethical committee and was conducted in accordance with the National Research Council's Guidelines for the Care and Use of Laboratory Animals. Male SHR (26 weeks old) were housed under controlled environmental conditions (22°C; 12:12-h light:dark period) with free access to commercial chow and water. Animals were randomly allocated into two groups to receive either Cr (n = 8; 5 g/kg/d) or placebo (Pl; n = 7; distillated water). The groups have similar body mass (Cr = 324.7 ± 41.9 vs. Pl = 325.2 ± 21.6; p = 0.97). Cr monohydrate was administered by gavage for nine weeks. Forty-eight hours after the intervention, arterial blood pressure and heart rate were invasively measured using a catheter inserted into the femoral artery [Citation14]. Thereafter, animals were killed by decapitation. Plasma, heart, carotid artery, plantaris, and extensor digitorum longus (EDL) muscles were isolated, weighted and deep frozen at -80°C for further analyses. Cardiomyocyte width and cardiac collagen deposition were also assessed by histological analyses, as measures of cardiac remodeling [Citation15]. Additionally, lipid hydroperoxidation (an important marker of oxidative stress) was determined in the plasma, heart, carotid artery, and skeletal muscles. These aforementioned methods have been described in details below.
Hemodynamic parameters
After an intra-peritoneal anesthetic injection (80 mg/kg ketamine and 12 mg/kg xylazine, i.p.), a catheter filled with 0.06 mL of saline was inserted into the femoral artery of rats. Twenty four hours after the catheter insertion, the arterial cannula was connected to a strain-gauge transducer (Blood Pressure XDCR; Kent Scientific, Torrington, CT, USA), and arterial pressure signals were recorded over a 30 min period in conscious rats by a microcomputer equipped with an analog-to-digital converter board (WinDaq, 2 kHz, DATAQ, Springfield, OH, USA). The recorded data were analyzed on a beat-to-beat basis to quantify systolic, diastolic and mean arterial pressure, as well as heart rate.
Histological analyses
Cardiac chambers were fixed by immersion in 4% buffered formalin and embedded in paraffin for routine histologic processing. Sections (4 μm) were stained with hematoxylin and eosin for examination by light microscopy. Only nucleated cardiac myocytes from areas of transversely cut muscle fibers were included in the analysis. Quantification of left ventricular fibrosis was achieved by Sirius red staining. Cardiac myocyte width and ventricular fibrosis were measured in the LV free wall with a computer assisted morphometric system (Leica Quantimet 500, Cambridge, UK).
Lipid hydroperoxidation measurement
Lipid hydroperoxidation was assessed since this oxidative stress marker has been implicated in the pathogenesis of a number of cardiovascular diseases, including arterial hypertension [Citation16, Citation17]. Lipid hydroperoxides were evaluated by the ferrous oxidation-xylenol orange technique (FOX2) [Citation18]. Plasma, Heart, Carotid Artery, Plantar and EDL samples were homogenized in phosphate-buffered saline (PBS; 100 mmol/L, pH 7.4) and immediately centrifuged at 12.000 g for 20 min at 4°C. The homogenate was precipitated with trichloroacetic acid (10% w/v) and centrifuged (12.000 g for 20 min at 4°C). Supernatant was mixed with FOX reagent (250 mmol/L ammonium ferrous sulfate, 100 mmol/L xylenol orange, 25 mmol/L H2SO4 and 4 mmol/L BHT in 90% methanol) and incubated at room temperature for 20 min. The absorbance of the sample was read at 560 nm in a spectrophotometer.
Statistical analysis
Data are expressed as mean ± standard error. The dependent variables were tested by unpaired Student's t test. Cohen's d effect size (Cr group minus placebo group divided by the standard deviation pooled) was also calculated for dependent variables. The level of significance was previously set at p < 0.05.
Results
As shown in Table , there were no significant differences in hemodynamic parameters between groups following the intervention.
Additionally, no significant differences between groups were shown in heart weight, cardiomyocyte width, and cardiac collagen content (Table ). Lipid hydroperoxidation also remained unchanged in the coronary artery, heart, plasma, plantaris, and EDL (Table ).
Comments
Cr intake failed to attenuate oxidative stress in the cardiovascular system (i.e., heart and artery) as well in other tissues (i.e., plasma and skeletal muscle) in SHR. Furthermore, Cr did not affect either the heart structure or the hemodynamic parameters. Altogether, these data suggest that Cr supplementation does not exert therapeutically relevant effects in a model of SHR.
It has been speculated that the coupling of Cr with ATP into the mitochondria could attenuate the formation of reactive oxygen species by stimulating the respiration rate and reducing the free energy required for ATP synthesis [Citation8]. Furthermore, Cr appears to act as a direct scavenger of radical species in face of oxidative stress [Citation8, Citation9]. These in vitro antioxidant proprieties confer to Cr a possible therapeutic role in diseases in which oxidative stress is exacerbated and related to pathological conditions. However, the current results were in contrast to our hypothesis. There are two potential speculations for the lack of any "positive" outcome in this study. First, the arterial blood pressure peaks at 24 weeks of age in SHR [Citation13]. Therefore, one may assume - despite the lack of a healthy control group - that our rats displayed severe arterial hypertension. In such extreme conditions, Cr may be not capable of reverting cardiovascular dysfunction. Second, Cr metabolism is divergent among species [Citation19], meaning that the in vitro antioxidant effects of Cr may not be extended to in vivo models. Further studies with other experimental models of hypertension as well as randomized controlled trials with humans are required to determine whether Cr supplementation can alleviate oxidative stress and cardiovascular dysfunction in arterial hypertension.
In summary, Cr supplementation did not affect oxidative stress or cardiovascular parameters in SHR model.
Abbreviations
ATP | = | Adenosine triphosphate |
Cr | = | Creatine |
EDL | = | Extensor digitorum longus |
SHR | = | Spontaneously hypertensive rats. |
Authors’ original file for figure 1
Download TIFF Image (1.5 MB)Authors’ original file for figure 2
Download TIFF Image (1.7 MB)Acknowledgements
We would like to thank Katt Coelho Mattos and Fabiana Guimarães for their valuable technical assistance in this study. We are grateful to FAPESP for the financial support. We also thank Ethika® for providing the supplements.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
CRRA was a significant writer and responsible for concept and design, experimental procedures, data analyses and interpretation. IHM, PR, HN and LRGB have participated in experimental procedures, data interpretation and manuscript preparation. AHLJ, PCB and MCI have participated in data interpretation and manuscript review. BG was a significant writer and responsible for data interpretation. All authors read and approved the final manuscript.
References
- HeistadDDWakisakaYMillerJChuYPena-SilvaRNovel aspects of oxidative stress in cardiovascular diseasesCirc J200973 2 201 207 2860751 1:CAS:528:DC%2BD1MXis1Wmurw%3D https://doi.org/10.1253/circj.CJ-08-1082 19110503
- HarrisonDGGongoraMCOxidative stress and hypertensionMed Clin North Am200993 3 621 635 1:CAS:528:DC%2BD1MXotFSqu70%3D https://doi.org/10.1016/j.mcna.2009.02.015 19427495
- GualanoBRoschelHLanchaAHJrBrightbillCERawsonESIn sickness and in health: the widespread application of creatine supplementationAmino Acids2011
- GordonAHultmanEKaijserLKristjanssonSRolfCJNyquistOSylvenCCreatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performanceCardiovasc Res199430 3 413 418 https://doi.org/10.1016/0008-6363(95)00062-3
- NeubauerSRemkesHSpindlerMHornMWiesmannFPrestleJWalzelBErtlGHasenfussGWallimannTDownregulation of the Na(?)-creatine cotransporter in failing human myocardium and in experimental heart failureCirculation1999100 18 1847 1850 1:CAS:528:DyaK1MXnsFSnsr0%3D https://doi.org/10.1161/01.CIR.100.18.1847 10545427
- MatthewsRTYangLJenkinsBGFerranteRJRosenBRKaddurah-DaoukRBealMFNeuroprotective effects of creatine and cyclocreatine in animal models of Huntington's diseaseJ Neurosci199818 156 163 1:CAS:528:DyaK1cXjtVKqtg%3D%3D 9412496
- HerschSMGevorkianSMarderKMoskowitzCFeiginACoxMComoPZimmermanCLinMZhangLUlugAMBealMFMatsonWBogdanovMEbbelEZaletaAKanekoYJenkinsBHeveloneNZhangHYuHSchoenfeldDFerranteRRosasHDCreatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dGNeurology200666 250 252 1:CAS:528:DC%2BD28XpsFGj https://doi.org/10.1212/01.wnl.0000194318.74946.b6 16434666
- SestiliPMartinelliCColomboEBarbieriEPotenzaLSartiniSFimognariCCreatine as an antioxidantAmino Acids201140 5 1385 1396 1:CAS:528:DC%2BC3MXkvFWqt7o%3D https://doi.org/10.1007/s00726-011-0875-5 21404063
- LawlerJMBarnesWSWuGSongWDemareeSDirect Antioxidant Properties of CreatineBiochem Biophys Res Commun2002290 1 47 52 1:CAS:528:DC%2BD38XhsFCisg%3D%3D https://doi.org/10.1006/bbrc.2001.6164 11779131
- SestiliPMartinelliCBraviGPiccoliGCurciRBattistelliMFalcieriEAgostiniDGioacchiniAMStocchiVCreatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activityFree Radic Biol Med200640 5 837 849 1:CAS:528:DC%2BD28XitVartrg%3D https://doi.org/10.1016/j.freeradbiomed.2005.10.035 16520236
- WallimannTTokarska-SchlattnerMSchlattnerUThe creatine kinase system and pleiotropic effects of creatineAmino Acids201140 1271 1296 3080659 1:CAS:528:DC%2BC3MXkvFWqt7k%3D https://doi.org/10.1007/s00726-011-0877-3 21448658
- MillsPCSmithNCHarrisRCHarrisPEffect of allopurinol on the formation of reactive oxygen species during intense exercise in the horseRes Vet Sci199762 11 16 1:CAS:528:DyaK2sXjslGqtLw%3D https://doi.org/10.1016/S0034-5288(97)90172-7 9160417
- TrippodoNCFrohlichEDSimilarities of genetic (spontaneous) hypertension: man and ratCirc Res198148 3 309 319 1:STN:280:DyaL3M7ht1Ggsg%3D%3D https://doi.org/10.1161/01.RES.48.3.309 7460205
- JorgeLRodriguesBRosaKTMalfitanoCLoureiroTCAMedeirosACuriRBrumPCLacchiniSMontanoNAngelisKIrigoyenMCCardiac and peripheral adjustments induced by early exercise training intervention were associated with autonomic improvement in infarcted rats: role in functional capacity and mortalityEur Hear J201132 7 904 912 https://doi.org/10.1093/eurheartj/ehq244
- FerreiraJCBacurauAVEvangelistaFSCoelhoMAOliveiraEMCasariniDEKriegerJEBrumPCThe role of local and systemic renin angiotensin system activation in a genetic model of sympathetic hyperactivity-induced heart failure in miceAm J Physiol Regul Integr Comp Physiol2008294 R26 R32 1:CAS:528:DC%2BD1cXhtVKgsr4%3D https://doi.org/10.1152/ajpregu.00424.2007 17977919
- RodrigoRPratHPassalacquaWArayaJGuichardCBächlerJPRelationship between oxidative stress and essential hypertensionHypertens Res200730 12 1159 1167 1:CAS:528:DC%2BD1cXktleksb8%3D https://doi.org/10.1291/hypres.30.1159 18344620
- Hermes-LimaMWillmoreWGStoreyKBQuantification of lipid peroxidation in tissue extracts based on Fe(III)xylenol orange complex formationFree Radic Biol Med199519 3 271 280 1:CAS:528:DyaK2MXntFGnur8%3D https://doi.org/10.1016/0891-5849(95)00020-X 7557541
- Nourooz-ZadehJTajaddini-SarmadiJWolffSPMeasurement of plasma hydroperoxide concentrations by the ferrous oxidation-xylenol orange assay in conjunction with triphenylphosphineAnal Biochem1994220 2 403 409 1:CAS:528:DyaK2cXlt12itLw%3D https://doi.org/10.1006/abio.1994.1357 7978285
- TarnopolskyMABourgeoisJMSnowRKeysSRoyBDKwiecienJMTurnbullJHistological assessment of intermediate- and long-term creatine monohydrate supplementation in mice and ratsAm J Physiol Regul Integr Comp Physiol2003285 4 R762 R769 1:CAS:528:DC%2BD3sXosVKju7g%3D https://doi.org/10.1152/ajpregu.00270.2003 12959920
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.